Investigational Site Number : 6040006

Lima LIMA 31

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early